An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer.

Nishimura, Reiki; Osako, Tomofumi; Okumura, Yasuhiro; Nakano, Masahiro; Ohtsuka, Hiroko; Fujisue, Mamiko; Arima, Nobuyuki

Nishimura, Reiki; Osako, Tomofumi; Okumura, Yasuhiro; Nakano, Masahiro; Ohtsuka, Hiroko; Fujisue, Mamiko; Arima, Nobuyuki.

Afiliación

Nishimura R; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.
Osako T; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.
Okumura Y; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.
Nakano M; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.
Ohtsuka H; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.
Fujisue M; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.
Arima N; Department of Pathology, Kumamoto Shinto General Hospital, Kumamoto, Kumamoto 862-8655, Japan.

Oncol Lett ; 24(2): 245, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35761943

Palabras clave

Ki-67; breast cancer; disease-free survival; estrogen receptor; lymphovascular invasion; progesterone receptor; receptor tyrosine-protein kinase erbB-2; subtype

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Lett Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google